Eltoprazine Dihydrochloride
≥98%
- Product Code: 59311
CAS:
143485-51-2
| Molecular Weight: | 293.19 g./mol | Molecular Formula: | C₁₂H₁₆N₂O₂₂HCl |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | room temperature, dry |
Product Description:
Eltoprazine dihydrochloride is primarily investigated for its potential therapeutic applications in treating various neurological and psychiatric conditions. It is being studied for its efficacy in managing aggression and impulsivity, particularly in disorders such as Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), and certain personality disorders. Its mechanism of action, which involves modulation of serotonin receptors, makes it a promising candidate for reducing aggressive behaviors without significant sedative effects.
Additionally, eltoprazine dihydrochloride is explored for its potential role in addressing motor disorders, including Parkinson’s disease and levodopa-induced dyskinesias. Its ability to influence dopaminergic pathways while balancing serotonin activity may help alleviate motor symptoms and improve patient quality of life. Preclinical and clinical trials continue to assess its safety, tolerability, and effectiveness in these applications, potentially offering a novel treatment option for complex neuropsychiatric and neurodegenerative conditions.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.010 | 10-20 days | ฿8,469.00 |
+
-
|
Eltoprazine Dihydrochloride
Eltoprazine dihydrochloride is primarily investigated for its potential therapeutic applications in treating various neurological and psychiatric conditions. It is being studied for its efficacy in managing aggression and impulsivity, particularly in disorders such as Alzheimer’s disease, attention deficit hyperactivity disorder (ADHD), and certain personality disorders. Its mechanism of action, which involves modulation of serotonin receptors, makes it a promising candidate for reducing aggressive behaviors without significant sedative effects.
Additionally, eltoprazine dihydrochloride is explored for its potential role in addressing motor disorders, including Parkinson’s disease and levodopa-induced dyskinesias. Its ability to influence dopaminergic pathways while balancing serotonin activity may help alleviate motor symptoms and improve patient quality of life. Preclinical and clinical trials continue to assess its safety, tolerability, and effectiveness in these applications, potentially offering a novel treatment option for complex neuropsychiatric and neurodegenerative conditions.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :